What is the appropriate treatment for tinnitus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Treatment for Tinnitus

For patients with persistent, bothersome tinnitus (≥6 months), clinicians should provide education/counseling as the foundation, recommend cognitive behavioral therapy (CBT), evaluate for hearing aids if hearing loss is present, and may offer sound therapy—while avoiding routine use of medications, supplements, or other unproven interventions. 1

Initial Assessment and Stratification

Before initiating treatment, distinguish between:

  • Bothersome vs. non-bothersome tinnitus: Only bothersome tinnitus requires active intervention 1
  • Recent onset vs. persistent (≥6 months): Persistent tinnitus warrants the treatment strategies below, as this duration matches RCT inclusion criteria 1
  • Presence of hearing loss: This fundamentally changes the treatment approach 1

Obtain comprehensive audiologic evaluation for any patient with unilateral tinnitus, persistent tinnitus ≥6 months, or hearing difficulties 1.

Evidence-Based Treatment Algorithm

First-Line Interventions (SHOULD Recommend)

1. Education and Counseling 1

  • Provide to ALL patients with persistent, bothersome tinnitus
  • Explain management strategies and natural history
  • Recent data shows counseling alone produces significant THI reduction and is the best initial treatment for most patients 2
  • This is the foundation upon which other therapies are built

2. Cognitive Behavioral Therapy (CBT) 1

  • Strong recommendation based on RCTs
  • Improves quality of life—the only treatment proven to do so 3
  • Consistently shows benefit across systematic reviews, with THI reductions up to -14.50 points 4
  • Combination of sound therapy with CBT-based counseling has the strongest evidence base 5

3. Hearing Aid Evaluation (if hearing loss present) 1

  • Recommend for ANY degree of hearing loss with persistent, bothersome tinnitus
  • Benefits apply even with mild or unilateral hearing loss 1
  • Improves both hearing function and quality of life 1
  • For patients with moderate-to-profound sensorineural hearing loss inadequately helped by hearing aids, cochlear implantation yields the largest treatment effects (THI reduction -29.97) 4

Second-Line Interventions (MAY Recommend)

4. Sound Therapy 1

  • Optional recommendation for persistent, bothersome tinnitus
  • Consistently improves tinnitus-related outcomes across systematic reviews 4
  • Can be combined with CBT for enhanced benefit 5

5. Tinnitus Retraining Therapy (TRT) 4

  • Shows consistent improvement in recent umbrella review
  • Not universally recommended across all guidelines due to variable evidence quality 6

Interventions to AVOID

Do NOT Routinely Recommend:

Medications 1

  • Antidepressants, anticonvulsants, anxiolytics, or intratympanic medications should NOT be used as primary tinnitus treatment
  • Evidence from systematic reviews and RCTs is insufficient despite some studies showing benefit
  • Known harms include side effects, cost, and potential for some medications (especially antidepressants) to worsen tinnitus
  • Exception: Treat comorbid depression or anxiety as separate conditions, not as primary tinnitus therapy
  • Caveat: A 2025 study showed nortriptyline-topiramate and verapamil-paroxetine combinations achieved MCID in ~40% of patients at moderate doses, but this represents emerging evidence requiring confirmation 7

Dietary Supplements 1

  • Do NOT recommend Ginkgo biloba, melatonin, zinc, or other supplements
  • RCTs and systematic reviews show no benefit
  • Avoid giving false hope and unnecessary expense

Transcranial Magnetic Stimulation (TMS) 1

  • Do NOT recommend for routine treatment
  • Based on inconclusive RCTs
  • Poses potential financial and physical harm without established benefit
  • Exception: May be indicated for comorbid depression or other neurological conditions

Acupuncture 1

  • No recommendation can be made due to poor quality trials
  • Shows no established benefit despite minimal harm

Key Clinical Pitfalls

  1. Don't delay audiologic evaluation: Obtain comprehensive audiometry promptly (within 4 weeks) for unilateral, persistent, or hearing-associated tinnitus 1

  2. Don't over-image: Only obtain head/neck imaging if tinnitus is unilateral, pulsatile, associated with focal neurologic abnormalities, or asymmetric hearing loss 1

  3. Don't prescribe medications reflexively: The evidence against routine pharmacotherapy is strong (Grade B), despite patient expectations 1

  4. Don't dismiss mild hearing loss: Hearing aids benefit tinnitus even with mild or unilateral hearing loss 1

  5. Don't treat all tinnitus the same: Only persistent (≥6 months), bothersome tinnitus requires active intervention 1

Evidence Quality Context

The 2014 American Academy of Otolaryngology-Head and Neck Surgery guideline [1-1 remains the primary evidence-based framework, with consistent recommendations across multiple systematic reviews. The most recent 2026 umbrella review 4 and 2025 VA/DOD guideline 8 confirm these core recommendations. CBT has the strongest evidence (RCT-based), while hearing aids rely on observational data but show high confidence in benefit. The evidence consistently prioritizes non-pharmacologic interventions that improve quality of life and function over medications with questionable efficacy and known harms.

References

1
Guideline

clinical practice guideline: tinnitus executive summary.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2014

2
Research

Initial Response to Combination Therapies for Tinnitus: Lessons Learned From a Retrospective Analysis.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2024

3
Research

Tinnitus: Diagnosis and Management.

American family physician, 2021

5
Research

Tinnitus.

Lancet (London, England), 2013

Related Questions

What causes tinnitus after watching TV and how should it be managed?
What is the appropriate evaluation and management for a 73-year-old man with new high‑frequency tinnitus in his right ear?
How should I manage a 30-year-old male with intermittent right‑ear tinnitus and occasional imbalance, no hearing loss, who has seen multiple physicians and experiences relief with antihistamines?
A 23-year-old patient reports tinnitus in his left ear; what evaluation and management steps are recommended?
For a 63-year-old woman with right‑ear tinnitus that worsens after loud noise exposure, without dizziness or hearing loss, what are the appropriate medications, management measures, and specialist referrals?
Which of the following statements about autoimmune hepatitis is false: a) Prednisolone 1 mg/kg body weight (corticosteroid step‑up therapy); b) Maintenance therapy may include low‑dose corticosteroids and azathioprine; c) A negative anti‑smooth muscle antibody excludes autoimmune hepatitis; d) Liver biopsy is the gold standard?
In a patient with multilevel lumbar degenerative disc disease, moderate facet hypertrophy at L2‑3, L4‑5, and L5‑S1, and a well‑positioned total right hip arthroplasty, what is the most likely cause of anterior thigh numbness and what evaluation and treatment steps are recommended?
How many standard alcoholic drinks per week are associated with a markedly increased risk of chronic alcoholic hepatitis in men and women?
How should tinnitus associated with vestibular migraine be treated?
What is the recommended neoadjuvant (induction) chemotherapy regimen for sinonasal undifferentiated carcinoma?
What is the recommended empiric antibiotic and dexamethasone regimen (including dosing) for adult bacterial meningitis, with adjustments for age, immunosuppression, Listeria risk, and β‑lactam allergy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.